Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$50.44−1.81 (-3.46%)
Close on Nov 13, 2026Market cap $3.60BP/E –Yield –
Pulse Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
Pulse Biosciences's gross margin for the twelve months ending Sep 30, 2026 was 26.8%. For fiscal 2025 it was -54.0%, against -1606.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -54.0% | +1552.3 |
| FY2022 | Dec 31, 2022 | -1606.3% | −1567.5 |
| FY2021 | Dec 31, 2021 | -38.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 51.6% | +276.1 |
| Q2 FY2026 | Jun 30, 2026 | 37.1% | +444.3 |
| Q1 FY2026 | Mar 31, 2026 | 7.7% | +112.5 |
| Q4 FY2025 | Dec 31, 2025 | 1.5% | +48.6 |
| Q3 FY2025 | Sep 30, 2025 | -224.4% | −197.8 |
| Q2 FY2022 | Jun 30, 2022 | -407.2% | – |
| Q1 FY2022 | Mar 31, 2022 | -104.7% | – |
| Q4 FY2021 | Dec 31, 2021 | -47.0% | – |
| Q3 FY2021 | Sep 30, 2021 | -26.7% | – |
See a number that looks wrong?